Wang, Y.; Lin, H.; Ou, Y.; Fu, H.; Tsai, C.; Chien, C.C.; Wu, C.
Safety Analysis of Bevacizumab in Ovarian Cancer Patients. J. Clin. Med. 2023, 12, 2065.
https://doi.org/10.3390/jcm12052065
AMA Style
Wang Y, Lin H, Ou Y, Fu H, Tsai C, Chien CC, Wu C.
Safety Analysis of Bevacizumab in Ovarian Cancer Patients. Journal of Clinical Medicine. 2023; 12(5):2065.
https://doi.org/10.3390/jcm12052065
Chicago/Turabian Style
Wang, Yingwen, Hao Lin, Yuche Ou, Hungchun Fu, Chingchou Tsai, Chanchao Chang Chien, and Chenhsuan Wu.
2023. "Safety Analysis of Bevacizumab in Ovarian Cancer Patients" Journal of Clinical Medicine 12, no. 5: 2065.
https://doi.org/10.3390/jcm12052065
APA Style
Wang, Y., Lin, H., Ou, Y., Fu, H., Tsai, C., Chien, C. C., & Wu, C.
(2023). Safety Analysis of Bevacizumab in Ovarian Cancer Patients. Journal of Clinical Medicine, 12(5), 2065.
https://doi.org/10.3390/jcm12052065